Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 9, 2021
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apollo Endosurgery, Inc.
| -1.95M |
—
|
—
| -49.81% | 1.96M |
Oct 30 - Feb 24
| |||||||
Apollo Endosurgery, Inc.
| -1.27M |
—
|
—
| -56.24% | 985.9K |
May 26
| |||||||
Apollo Endosurgery, Inc.
| 363.5K |
$5.50 | $1,999,250.00 | +676.72% | 417.21K |
Jun 20
| |||||||
Apollo Endosurgery, Inc.
| 4.04K |
$6.20 | $25,035.60 | +8.13% | 53.72K |
Mar 9
| |||||||
Apollo Endosurgery, Inc.
| -1.26M |
—
|
—
| -96.21% | 49.68K |
Nov 15
| |||||||
Apollo Endosurgery, Inc.
| 176K |
$3.89 | $685,390.00 | +16.13% | 1.27M |
Sep 5 - Sep 12
| |||||||
Apollo Endosurgery, Inc.
| 1.09M |
$5.50 | $5,999,999.50 | +26.27% | 5.24M |
Jul 25
| |||||||
Apollo Endosurgery, Inc.
| 1.14M |
$5.50 | $6,249,996.50 |
∞
| 1.14M |
Jul 25
| |||||||
Lpath, Inc
| 4.15M |
—
|
—
|
∞
| 4.15M |
Dec 29
| |||||||
Lpath, Inc
| 4.15M |
—
|
—
|
∞
| 4.15M |
Dec 29
| |||||||
0
|
—
|
—
|
—
|
0
| |||||||||
0
|
—
|
—
|
—
|
0
| |||||||||
Intersect Ent, Inc.
| -644.24K |
—
|
—
| -25.00% | 1.93M |
Jan 19
| |||||||
Intersect Ent, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Ldr Holding Corp
| 1.95M |
$15.00 |
—
| +2,182.45% | 2.04M |
Oct 15
| |||||||
Ldr Holding Corp
|
0
|
—
|
—
|
—
|
0
| ||||||||
Bioform Medical Inc
| 6.05M |
—
|
—
| +2,065.61% | 6.34M |
Nov 9
| |||||||
Bioform Medical Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Insite Vision Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||